Patient engagement with an asthma app to improve inhaler adherence

Jácome, Cristina; Almeida, Rute; Amaral, Rita; Pereira, Ana Margarida; Bom, Ana Todo; Azevedo, João; Pinto, Paula; Neuparth, Nuno; Bom, Filipa Todo; Costa, Alberto; Loureiro, Cláudia Chaves; Arrobas, Ana; Valério, Margarida; Cardoso, João; Rodrigues, José Carlos Cidrais; Oliveira, Georgeta; Carvalho, Joana; Mendes, Ana; Lozoya, Carlos; Santos, Natacha; Menezes, Fernando; Gomes, Ricardo; Câmara, Rita; Alves, Rodrigo Rodrigues; Moreira, Ana Sofia; Bordalo, Diana; Alves, Carlos; Coelho, Didina; Ferreira, José Alberto; Lopes, Cristina; Silva, Diana; Vasconcelos, Maria João; Teixeira, Maria Fernanda; Taborda-Barata, Luís; Cálix, Maria José; Alves, Adelaide; Fonseca, João Almeida

doi:10.1183/13993003.congress-2020.1353

Cited by 2 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 55 Reminder systems and gamification of the management, including digital and real‐life rewards, may seem like obvious choices. 56 However, a recent meta‐analysis found important limitations regarding the evidence supporting the potential effects of mHealth in asthma control. They found that these interventions have only reported modestly improvement of inhaler adherence and reduction of rescue inhaler use, without an actual impact on asthma control.…”

Section: Ehealth For Patients and Patient Representativesmentioning

confidence: 99%

“…mHealth has been proposed as a possible solution to these challenging clinical situations 55 . Reminder systems and gamification of the management, including digital and real‐life rewards, may seem like obvious choices 56 . However, a recent meta‐analysis found important limitations regarding the evidence supporting the potential effects of mHealth in asthma control.…”

Section: Ehealth For Patients and Patient Representativesmentioning

confidence: 99%

See 1 more Smart Citation

The applications of eHealth technologies in the management of asthma and allergic diseases

Alvarez-Perea

Dimov

Popescu

et al. 2021

Clinical & Translational All

View full text Add to dashboard Cite

Portable devices, such as smartphones and mobile Internet access have become ubiquitous in the last decades. The term ‘eHealth’ stands for electronic health. The tools included in the eHealth concept utilize phones, computers and the Internet and related applications to improve the health care industry. Implementation of eHealth technologies has been documented for the management of different chronic diseases, including asthma and allergic conditions. Clinicians and patients have gained opportunity to communicate in new ways, which could be used cost‐effectively to improve disease control and quality of life of those affected. Additionally, these innovations bring new opportunities to academic researchers. For example, eHealth has allowed researchers to compile data points that were previously unavailable or difficult to access, and analyse them using novel tools, collectively described as ‘big data’. The role of eHealth become more important since early 2020, due to the physical distancing rules and the restrictions on mobility that have been applied worldwide as a response to the coronavirus disease 2019 pandemic. In this review, we summarize the most recent developments in various eHealth platforms and their relevance to the speciality of allergy and immunology, from the point of view of three major stakeholders: clinicians, patients and researchers.

show abstract

Section: Ehealth For Patients and Patient Representativesmentioning

confidence: 99%

Section: Ehealth For Patients and Patient Representativesmentioning

confidence: 99%

The applications of eHealth technologies in the management of asthma and allergic diseases

Alvarez-Perea

Dimov

Popescu

et al. 2021

Clinical & Translational All

View full text Add to dashboard Cite

show abstract

“…Several digital technologies have been or are currently being developed to support parents and health professionals, especially at the primary care level, in the management of wheezing disorders. These include symptom diaries [ 9 , 10 ] and asthma action plans accessible within mobile health applications for smartphones [ 11 ], adherence support via gamification [ 12 ], digital therapeutics such as smarthalers [ 13 ], or digitally connected diagnostic tools like wirelessly connected peak flow meters [ 14 ], digital stethoscopes for health care professionals [ 15 ] or mobile wheeze [ 16 , 17 ], and cough detectors [ 18 ]. The market for mobile phone applications is growing remarkably every year, but no quality control system is in place to distinguish guideline-based medical support from arbitrarily compiled or simply wrong content [ 19 ].…”

Section: Introductionmentioning

confidence: 99%

The impact of a digital wheeze detector on parental disease management of pre-school children suffering from wheezing—a pilot study

Dramburg

Dellbrügger²,

Aalderen

et al. 2021

Pilot Feasibility Stud

View full text Add to dashboard Cite

Background Viral airway infections are a major reason for doctor’s visits at pre-school age, especially when associated with wheezing. While proper treatment requires adequate recognition of airway obstruction, caretakers are often struggling with this judgment, consequently leading to insufficient or late treatment and an unnecessary discomfort of the patient. Digital technologies may serve to support parental decision taking. The aim of the present pilot study is to acquire data on the feasibility of recruitment and observation procedures for a randomized controlled trial on the impact of a digital wheeze detector in a home management setting of pre-school wheezing. Methods This single-armed pilot study enrolled patients with a doctor’s diagnosis of wheezing aged 9 to 72 months. Participants were asked to use a digital wheeze detector (WheezeScan, Omron Healthcare, Japan) 2×/day for 30 days and record the child’s respiratory symptoms, detection of wheezing, and medication intake via an electronic diary (eDiary) app. Demographic and clinical data were collected at the recruitment visit. The asthma control test and the Parent Asthma Management Self-Efficacy Scale (PAMSES) were assessed both, at recruitment and follow-up. Results Twenty families were recruited and completed the monitoring. All but one completed the follow-up after 30 days. The recruitment procedures were feasible, and adherence to daily monitoring reached an average of 81%. The use of the wheeze detector was rated as uncomplicated. Parents detected wheezing without digital support in only 22/708 (3.1%) of the recorded events. By contrast, the wheeze detector indicated an airway obstruction in 140/708 (19.8%) of the recordings. Conclusion In parallel to feasible recruitment procedures, we observed good usability of the wheeze detection device and high adherence to eDiary recording. The positive outcomes show that the WheezeScan may empower parents by increasing their capacity for wheeze detection. This deserves to be investigated in a larger randomized controlled trial.

show abstract

Patient engagement with an asthma app to improve inhaler adherence

Cited by 2 publications

References 0 publications

The applications of eHealth technologies in the management of asthma and allergic diseases

The applications of eHealth technologies in the management of asthma and allergic diseases

The impact of a digital wheeze detector on parental disease management of pre-school children suffering from wheezing—a pilot study

Contact Info

Product

Resources

About